Health Care & Life Sciences » Pharmaceuticals » Personalized medicine | Personalized medicines among FDA approved new molecular entities 2016

Personalized medicines as percent of new molecular entities 2005 and 2016

Personalized medicines as a percentage of FDA approved new molecular entities in 2005 and 2016

The data shows the percentage of personalized medicines among FDA approved new molecular entities in 2005 and 2016. In 2005, personalized medicines accounted for 5% of the total FDA approved new molecular entities, while in 2016 they accounted for 27% of approved new molecular entities.

2005	5
2016	27

Personalized medicines as percent of new molecular entities 2005 and 2016

StatInvestor